'Intensive treatment' presentation slideshows

Accessing Community Behavioral Health Resources

Accessing Community Behavioral Health Resources. Developed by DATA of Rhode Island Through a special grant from the Rhode Island Department of Human Services September 2006. Treatment - The System of Care. Components of SA Treatment System.

817 views • 62 slides

704 views • 54 slides

The Science: CHD and Diabetes as Co-morbidities

The Science: CHD and Diabetes as Co-morbidities. Kathy Reims, MD Center for Strategic Innovation 8/27/07. Objectives:. What is the rationale to think about diabetes and coronary heart disease (CHD) together? Patient perspective Pathophysiology Treatment

520 views • 44 slides

Intensive Treatments for Children and Adolescents with Anxiety Disorders

534 views • 41 slides

Obsessive-compulsive disorder

Obsessive-compulsive disorder. Clinical Guideline Published: November 2005. NICE clinical guidelines. Recommendations for good practice based on best available evidence of clinical and cost effectiveness

673 views • 35 slides

CDC Best Practices - States Roundtable Treatment of Tobacco Use and Dependence

CDC Best Practices - States Roundtable Treatment of Tobacco Use and Dependence. Michael Burke, EdD Thomas Payne, PhD Christine Sheffer, PhD Ken Wassum, BA. ATTUD, 2008.

423 views • 32 slides

423 views • 29 slides

309 views • 21 slides

Marcus Cuffie Pharm. D. Candidate Preceptor: Dr. Ali Rahimi September 23, 2011

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster- randomised [sic] trial.

282 views • 20 slides

Michael Dennis, Ph.D.* Christy K Scott, Ph.D.** and Mark D. Godley, Ph.D.*

Substance Abuse Treatment Reduces Costs to Society; Eliminating Substance Abuse Treatment Increases Costs. Michael Dennis, Ph.D.* Christy K Scott, Ph.D.** and Mark D. Godley, Ph.D.* Chestnut Health Systems, *Normal & **Chicago, IL February 22, 2011

323 views • 17 slides

AUTISM AND PERVASIVE DEVELOPMENTAL DISORDERS LECTURE OUTLINE History and background

352 views • 17 slides

Changing Interventions: Creating Innovation Worth Sustaining

Changing Interventions: Creating Innovation Worth Sustaining. RBS Implementation Preparation Forum November, 2008 Sacramento, California. Key Themes in RBS. RBS Elements. Structure: How does a community & system organize to accomplish better goals and objectives?

266 views • 16 slides

The ADDITION-Europe study

341 views • 15 slides

Therapy of Type 2 Diabetes Mellitus: UPDATE

Therapy of Type 2 Diabetes Mellitus: UPDATE. Glycemic Goals in the Care of Patients with Type 2 Diabetes- 2013 ADA and AACE Guidelines: Room For Improvement (Be HAPPY/ Avoid Burnout, While Caring for Patients with DM). Stan Schwartz MD, FACP, FACE Affiliate, Main Line Health System

368 views • 14 slides

Senate Criminal Justice Committee

Senate Criminal Justice Committee. Interim Charge 1 June 21, 2006. Public Mental Health System in Texas. DSHS mental health services are only part of the public mental health system in Texas.

382 views • 13 slides

Diabetes Mellitus

Diabetes Mellitus. Overview. A heterogeneous group of syndromes characterized by an elevation of fasting blood glucose caused by absolute or relative deficiency of insulin Two types of DM : Type 1 (insulin-dependent DM) Type 2 (noninsulin dependent DM)

454 views • 13 slides

Diabetes Mellitus

Diabetes Mellitus. Type I. Insulin-dependent / Type I DM. require insulin autoimmune attack on ? -cells symptoms : when 80% to 90% of ? -cells are destroyed. Glucose tolerance test. 75 g of glucose after overnight fast blood glucose every 30 minutes Diabetics: 140 mg/dL (initial)

507 views • 11 slides

Lee Silverman Voice Treatment (LSVT)

338 views • 10 slides

BLOOD CANCER- ITS TYPES, SYMPTOMS AND TREATMENT | Medmonks

Blood cancer can be classified into three types namely Leukemia, Lyphomate and Mylemoa. To get more information click here: https://goo.gl/79XgCR

797 views • 10 slides

Steno-2: study design

Steno-2: study design. Patents with type 2 diabetes and microalbuminuria (n = 160). Stratification by urinary albumin excretion. Randomisation. Intensive therapy (n = 80). Conventional therapy (n = 80). Stepwise behaviour modification

1.15k views • 7 slides